Effects of the combination of ezetimibe and rosuvastatin on blood-lipids and high sensitive C-reactive protein in patients with cerebral infarction

XU Yuan,XU Zhi-hong,WU Yan-hua,LIU Yuan,LIU Chun-feng

DOI: https://doi.org/10.3969/j.issn.1672-5921.2013.06.008

2013-01-01

Abstract:Objective To observe the effects of the combination of ezetimibe and rosuvastatin on blood-lipids,high sensitive C-reactive protein(hs-CRP) and von Willebrand factor(vWF) in patients with cerebral infarction.Methods A total 86 patients with acute cerebral infarction were enrolled prospectively.They were randomly assigned to a 10 mg statin group(rosuvastatin 10 mg/d,n=30),a 20 mg statin group(rosuvastatin 20 mg/d,n=27) and a combined group(ezetimibe 10 mg/d,rosuvastatin 10 mg/d,n=29).They were treated for 16 weeks.The changes of blood-lipids,hs-CRP,vWF,alanine aminotransferase(ALT),aspartate aminotransferase(AST),and creatine kinase(CK) were compared before and after treatment.Results ①Compared with before treatment,the levels of low-density lipoprotein(LDL-C) and cholesterol(TC) in all groups were deceased after treatment(P<0.01).②After 16 weeks of treatment,the levels of LDL-C,TC,hs-CRP and vWF in the 20 mg statin group and the combined group were lower than those in the 10 mg statin group.There were significant differences(P<0.01).③No patients withdrew because of adverse reaction among the three groups during the treatment.After 16 weeks of treatment,there were no significant differences in ALT,AST and CK among the groups before and after treatment(P>0.05).Conclusion The combination of ezetimibe and rosuvastatin is better than 10 mg rosuvastatin alone in lowering the effect of LDL-C and TC.